Anavex Life Sciences Corp (AVXL)

[williamssc]

The cognitive endpoint ADAS-Cog13 showed statistically significant slowing of decline. The ADCS-ADL did show to trend upward. In the OLE, ADCS-ADL differences became more favorable over time even reaching reaching stat sig. It's been pointed out that subtle changes in daily living are harder for family members to detect in the short term. So we have a safe effective oral treatment going before regulators.